Immunotherapy For The Treatment Articles & Analysis: Older
9 articles found
Summary In this Cell Patterns publication, Ozette co-founders and collaborators at the Cancer Immunotherapy Trials Network (CITN) outline a novel method of analysis of single cell data, FAUST, and validate the multiple potential applications. ...
Our research, along with our partners at Duke Health, found there were significant health care delays for people of color when they tried to obtain immunotherapy treatment. Delays related to timeliness in obtaining treatment can be complex and multifactorial and cause differential access to treatment. ...
Evaluating mass implementation of digital health solutions to improve quality and reduce disparities in a large multisite community oncology practice (Oral Presentation) Analyzing patient engagement with digital health tools to facilitate equity across a large statewide community oncology practice (Poster Presentation) Racial disparity in receipt of immunotherapy ...
No approved preventive vaccines, immunotherapies, or reliable treatments are currently available to cure herpes, says the WHO and the U.S. ...
Therapeutic vaccines may well be the next wave of immunotherapy for cancer treatment. Peptide-based vaccines will play a pivotal role in the field. ...
About Treos Bio Limited Treos Bio uses computational data science and proprietary biomarkers to develop precision off-the-shelf and personalized peptide-based cancer immunotherapies. The Company has developed a unique ability to match the antigens expressed by a specific cancer to the individual patient’s target recognition mechanism (HLA). This technology aims to address ...
How autoantibody profiling can further unlock the success of CPI therapy Immunotherapy has revolutionised the treatment of cancers, improving the prognosis for a variety of malignancies. One of the key elements in the immunotherapy war chest are checkpoint inhibitors (CPIs) which have been the main drivers behind this progress. ...
The research summarized in this whitepaper provides a number of examples of how ALZET® pumps offer a superior pre-clinical drug dosing option for the delivery of a wide array of anti-cancer agents, including small molecules, immunotherapies, radiotherapies, combination treatments, and novel drug entities. This whitepaper also explores how ALZET® pumps ...
Future Treatment: Immunotherapies Immunotherapies have been adopted as an approach to treating autoimmune conditions such as type 1 diabetes. ...